???global.info.a_carregar???
Dr. Catarina M. Abreu has an integrated MSc degree in Biological Engineering in 2016 from Instituto Superior Técnico, University of Lisbon (PT) in collaboration with the International Iberian Nanotechnology Laboratory (INL, PT). Her MSc research was dedicated to the development of point-of-care medical devices for rare cancer cell isolation from body fluids using cutting-edge nanotechnological tools (doi:10.3389/fonc.2020.01774, IF: 4.848). In that same year, Catarina was selected for an International PhD position in Swansea University Medical School (UK), one of the top 5 Medical schools in the UK according to The Guardian ranking in 2020. In January 2017, Catarina initiated her PhD project in “Biosensors for enhanced in vitro fertilization outcomes” within an international consortium involving Swansea University and INL. During this period, Dr. Abreu acquired broad expertise in cleanroom microfabrication where she fabricated and characterized graphene electrolyte-gated field effect transistors (G-EGFET) and electrochemical sensors. Her knowledge in Chemistry/Physics and experience in Biology/Clinical sample processing led her to successfully functionalize and operate sensors for several medical applications. The multidisciplinary profile of the researcher enabled her to underpin the development of a promising biomarker screening approach for the non-invasive embryo selection. Catarina discovered a correlation between molecular profiles and developmental competence of human embryos through the analysis of embryo-secreted molecules to the culture media. Due to the innovative and groundbreaking potential of this technology, this work was published in the prestigious Biosensors and Bioelectronics journal (doi:10.1016/j.bios.2020.112144, IF:10.257). Catarina has also developed additional expertise in the fields of neurodegenerative diseases and epigenetics where she worked very constructively and effectively with her colleagues at INL and Swansea, and from which resulted three publications. During her PhD, Dr. Abreu was involved in the writing of several national and international proposals, from which resulted the direct funding of Biogen Pharmaceuticals, while also participating on ongoing funded award-winning projects (I3S-Hovione Capital Prize award). In 2020, Catarina joined the 3B’s Research Group from University of Minho (Portugal), as world-recognized institute in TERM and biomaterials, as a postdoctoral researcher to develop a new generation of tumor-on-chip models with integrated biosensors to study the role of the tumor microenvironment in cancer progression and metastasis. Despite her young age, her skills and initiative lead her to become co-responsible of the cleanroom facility and co-manager of the development of in-house biosensors, while also being involved in a variety of national and international collaborations. The most recent collaboration envisions the engineering of innovative nanotechnological-based solutions for the high-throughput isolation and characterization of exosomes from biological samples by the combination of microfluidics and biosensors to create liquid biopsy systems. During her brief scientific career, Catarina has trained new researchers (MSC and PhD) on advanced systems and has authored 6 publications in high impact journals, 1 book chapter, 2 papers to be submitted/accepted and has several in progress.
Identificação

Identificação pessoal

Nome completo
Catarina Filipa Matoso Abreu

Nomes de citação

  • Abreu, Catarina M.

Identificadores de autor

Ciência ID
6F13-6510-4381
ORCID iD
0000-0001-9116-2395

Telefones

Telefone
  • 253510900 (Profissional)

Moradas

  • AvePark - Parque de Ciência e Tecnologia, Zona Industrial da Gandra, , 4805-017, Barco, Guimarães, Portugal (Profissional)

Websites

  • https://3bs.uminho.pt/users/catarinaabreu (Profissional)

Domínios de atuação

  • Ciências Médicas e da Saúde - Biotecnologia Médica - Biotecnologia Aplicada à Saúde
  • Ciências Naturais - Ciências Biológicas - Biologia da Reprodução
  • Ciências da Engenharia e Tecnologias - Nanotecnologia
  • Ciências da Engenharia e Tecnologias - Nanotecnologia - Nanoprocessos
  • Ciências Naturais - Ciências Biológicas - Biologia
  • Ciências da Engenharia e Tecnologias - Nanotecnologia - Nanomateriais
  • Ciências Médicas e da Saúde - Biotecnologia Médica - Biomateriais

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Formação
Grau Classificação
2017/01 - 2019/12
Concluído
PhD in Medicine in collaboration with the International Iberian Nanotechnology Laboratory (Doutoramento)
Swansea University Medical School, Reino Unido
"Biosensors for enhanced in vitro fertilisation outcomes" (TESE/DISSERTAÇÃO)
2011/09 - 2016/10
Concluído
Biological Engineering (Mestrado integrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
"Microfluidic isolation and characterisation of bladder cancer cells from urine for early and non-invasive diagnosis of bladder cancer" (TESE/DISSERTAÇÃO)
Percurso profissional

Ciência

2020/07/01 - Atual Pós-doutorado (Investigação)
Universidade do Minho, Portugal
2017/01/01 - 2020/03/31 Investigador (Investigação)
Swansea University Medical School, Reino Unido
2017/01 - 2019/12 Investigador visitante (Investigação)
International Iberian Nanotechnology Laboratory, Portugal
2016/02 - 2016/09 Estagiário de Investigação (Investigação)
International Iberian Nanotechnology Laboratory, Portugal